Then, the potential association between TOP2A genetic alteration and the clinical survival prognosis of ovarian serous cystadenocarcinoma patients was analyzed based on these seven ovarian serous cystadenocarcinoma cases detected using the cBioportal For Cancer Genomics online tool. This evidence concerns the gene TOP2A and ovarian serous cystadenocarcinoma.